Sodium Chloride Hypertonicity Ophthalmic Ointment, 5%, 1/8 oz. (3.5 g) tube per carton, Distribut...
FDA Drug Recall #D-1411-2014 — Class II — April 10, 2014
Recall Summary
| Recall Number | D-1411-2014 |
| Classification | Class II — Moderate risk |
| Date Initiated | April 10, 2014 |
| Status | Terminated |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | Bausch & Lomb, Inc. |
| Location | Tampa, FL |
| Product Type | Drugs |
| Quantity | 35,253 tubes |
Product Description
Sodium Chloride Hypertonicity Ophthalmic Ointment, 5%, 1/8 oz. (3.5 g) tube per carton, Distributed by Major Pharmaceuticals, 31778 Enterprise Drive, Livonia, MI 48150, NDC 0904-5315-38, UPC 3 09045 31538 5.
Reason for Recall
Crystallization: Crystal precipitate formation and an increase in the number of complaints associated with a gritty, sand-like feeling in the eye.
Distribution Pattern
Nationwide, Puerto Rico, Canada, and Hong Kong.
Lot / Code Information
Lot #'s: 159101, Exp 02/15; 169271, Exp 09/15; and 170481, Exp 10/15
Other Recalls from Bausch & Lomb, Inc.
| Recall # | Classification | Product | Date |
|---|---|---|---|
| D-0899-2017 | Class II | NasalCrom (cromolyn sodium) Nasal Spray, USP, 5... | Jun 6, 2017 |
| D-0645-2016 | Class III | Cyclopentolate Hydrochloride Ophthalmic Solutio... | Jan 18, 2016 |
| D-0646-2016 | Class III | Tropicamide Ophthalmic Solution USP, 0.5%, Pack... | Jan 18, 2016 |
| D-0647-2016 | Class III | Tropicamide Ophthalmic Solution USP, 1%, Packag... | Jan 18, 2016 |
| D-1349-2015 | Class II | Bromfenac Ophthalmic Solution, 0.09%, 1.7 mL Bo... | Aug 17, 2015 |
Frequently Asked Questions
Stop taking the medication and contact your pharmacist or doctor immediately. For Class I recalls, this is urgent. For Class II or III recalls, consult your doctor before stopping — abruptly discontinuing certain medications (blood pressure drugs, antidepressants, diabetes medications) can be more harmful than continuing while arranging a replacement. Check whether the recall applies to your specific lot number and expiration date. Return the product to your pharmacy and report any adverse effects to FDA MedWatch at 1-800-FDA-1088.
Not necessarily. Many drug recalls are initiated because of quality system failures or test results that suggest a product might not meet specifications — even if no patients have reported harm. The FDA uses a precautionary approach: if there is reason to believe quality standards were not met, a recall is required regardless of whether adverse effects have been reported. Class I recalls typically involve a reasonable probability of harm; Class II recalls may cause temporary health issues; Class III recalls are for products unlikely to cause adverse health consequences but that still violate regulations.
Pharmacies typically receive recall notices directly from drug wholesalers and manufacturers within days of the recall being announced. Your pharmacist can look up whether any product in your prescription history matches a recalled lot number. For current recalls, the FDA publishes updates at FDA.gov/safety/recalls-market-withdrawals-safety-alerts and sends MedWatch email alerts for significant drug safety issues. You can sign up for MedWatch alerts at FDA.gov. Most major pharmacy chains also have their own recall notification systems that automatically alert pharmacists when a recalled product is in their inventory.
What Should You Do?
Stop using this medication if affected by this recall. Contact your pharmacist or prescribing doctor immediately for guidance. Do not flush medications — use a drug take-back program.